Xavier Champavere

Part of Sanofi, Sanofi-Synthélabo Ltd. is a pharmaceutical company based in Reading, UK. The British company was founded in 1990 and specializes in manufacturing and distributing solid-dose and pharmaceutical products.

HUYA Bioscience International LLC develops biopharmaceutical products. It sources pharmaceutical innovation originating in China for global development in international markets. It's lead immune-oncology lead product, HBI-8000, already approved in China, is now in registration trials in Japan and Korea for lymphoma and in clinical trials in the U.S. for various solid tumor indications in combination with the checkpoint inhibitor nivolumab. The company was founded by Mireille Gillings in 2004 and is headquartered in San Diego, CA.

Alain Afflelou Franchiseur SAS develops and operates optical goods stores. The firm specializes in the manufacture and retail distribution of sunglasses, contact lenses, eyeglass frames, and eyewear supplies and accessories. The company was founded in 1979 and is headquartered in Paris, France.

The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA.

Part of Interpublic Group of Cos., Inc., Migliara Kaplan & Associates is a full-service health care marketing company. The company is based in Owings Mills, MD. The company was founded by Joseph M. Migliara, Harris Kaplan. Migliara Kaplan & Associates was acquired by NFO Research, Inc. on January 09, 1996 for $15.20 million.

French Academy of Sciences engages in protection of spirit of French scientific research. The firm offers science teaching, transmitting knowledge, international collaboration and advice. The company was founded by Jean-Baptiste Colbert in 1666 and is headquartered in Paris, France.

Hunza Management SARL is a private equity firm headquartered in Luxembourg. The current firm was established in 1998 to manage Hunza Ventures, the venture capital investment vehicle of the family of the retired Belgian entrepreneur Guy Ullens. Baron Guy Ullens de Schooten and the Wittouck family built up and controlled the diversified European food manufacturing group Artal, based in Luxembourg and historically focused on the Belgian sugar industry.

Hunza Ventures II SCA SICAR focuses on making investments in the biotech, pharmaceutical, medtech and high-tech industries.

Part of Lundbeck Foundation, Lundbeck, Inc. is a pharmaceutical company that produces pharmaceutical preparations. The company is based in Paramus, NJ. The company was founded by Jeffrey S. Aronin.

Part of Somadin, Herpain Urbis NV is a Belgian real estate development company. The company is based in Brussels, Belgium. Herpain Urbis was founded by Laurent J. Degryse. The CEO is Yvan Neirinckx.

Tang Freres SA owns and operates as supermarkets. The company was founded in 1976 and is headquartered in Paris, France

Part of Rubis SCA, SA de la Raffinerie des Antilles is a French company that owns and operates an oil refinery. The company is based in Le Lamentin, France. The company was founded in 1969. Philippe Guy has been the CEO of the company since 2016.

Sanofi-Aventis Recherche et Développement SA is a pharmaceutical company based in Chilly-Mazarin, France. Part of Sanofi, Sanofi-Aventis Recherche et Développement SA is a French company that focuses on delivering medicines and vaccines for millions of people around the world. The company's R & D teams work closely with patient communities affected by rare hematological disorders to offer them effective and innovative therapeutic care. Find out more about rare hematological disorders in R&D. The company was founded in 1900. Lionel Joël Bascles has been the CEO of the company since 2018.

Noorik Biopharmaceuticals AG is a Swiss drug development company. The private company is based in Basel, Switzerland.

Cardiorentis AG operates as a biopharmaceutical company. It offers novel therapies to the treatment of heart failure and related cardiovascular diseases. The company was founded in 2010 and is headquartered in Zug, Switzerland.

UCB Pharma Ltd. operates as a biopharmaceutical company. The firm focuses on developing medicines for severe diseases in Immunology and CNS. The company is headquartered in Slough, the United Kingdom.

MindMaze SA engages in the development of a neuro-inspired computing platform that captures brain activity upon intent, creating a new operating system for computers. It also engages in the use of virtual reality to rehabilitate the brains of stroke patients. The company was founded by Tej Tadi in 2012 and is headquartered in Lausanne, Switzerland.

Biolog-id SAS develops radio frequency identification electronic tags. It is a designer-integrator specializing in the development of traceability solutions for health products, such as labile blood products (packed red blood cells, platelets, therapeutic plasma), plasma for fractionation and cancer chemotherapy. The company was founded in 1981 and is headquartered in Paris, France.

American Discovery Capital LLC (American Discovery) is a private equity firm founded in 2016 by John P. Joliet. The firm is headquartered in Los Angeles. California.

Griffon Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The private company is based in Montréal, Canada.

Herpain Urbis Retail Holding SA is an investment holding Belgian company. The private company is based in Uccle, Belgium. The company was founded in 2015. Yvan Neirinckx has been the CEO of the company since 2015.

The Museum of Contemporary Art, Los Angeles operates a gallery for contemporary art. It services include collection, presentation, and interpretation of art and to preserving for future generations. The company was founded in 1979 and headquartered in Los Angeles, CA.

Sony Depthsensing Solutions SA/NV provides gesture-based platforms for the consumer electronics and professional markets. Its products include depthsense sensors, depthsense cameras and depthsense middleware. The company was founded by Eric Krzelso, Michel Tombroff and Daniel van Nieuwenhove in July 2007 and is headquartered in Brussels, Belgium.

Sony Depthsensing Solutions Holding SA provides image sensor technology. It offers a complete family of 3 dimensional imaging and gesture recognition solutions, including patented 3D complementary metal-oxide semiconductor (CMOS) time-of-flight sensors and cameras, multi-platform and multi-camera 3D gesture recognition middleware, and tools as well as games and applications. The company was founded by Eric Krzeslo and Daniël Van Nieuwenhove in July 2007 and is headquartered in Brussels, Belgium.

Pacific Oak Strategic Opportunity REIT II, Inc. operates as a real estate investment trust. It intends to acquire distressed debt, to originate and acquire mortgage, mezzanine, bridge and other real estate-related loans, to invest in various types of opportunistic real estate and to invest in real estate-related debt securities such as residential and commercial mortgage-backed securities and collateralized debt obligations. The company was founded on February 6, 2013 and is headquartered in Los Angeles, CA.